
Syndax Pharmaceuticals Inc
NASDAQ:SNDX

Intrinsic Value
The intrinsic value of one
SNDX
stock under the Base Case scenario is
16.83
USD.
Compared to the current market price of 9.26 USD,
Syndax Pharmaceuticals Inc
is
Undervalued by 45%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
Syndax Pharmaceuticals Inc
Fundamental Analysis


Revenue & Expenses Breakdown
Syndax Pharmaceuticals Inc
Balance Sheet Decomposition
Syndax Pharmaceuticals Inc
Current Assets | 548.8m |
Cash & Short-Term Investments | 516.3m |
Receivables | 21.5m |
Other Current Assets | 11m |
Non-Current Assets | 92m |
Long-Term Investments | 89.9m |
PP&E | 1.8m |
Other Non-Current Assets | 217k |
Free Cash Flow Analysis
Syndax Pharmaceuticals Inc
USD | |
Free Cash Flow | USD |
Earnings Waterfall
Syndax Pharmaceuticals Inc
Revenue
|
43.7m
USD
|
Cost of Revenue
|
-17.7m
USD
|
Gross Profit
|
26m
USD
|
Operating Expenses
|
-369.7m
USD
|
Operating Income
|
-343.7m
USD
|
Other Expenses
|
12.5m
USD
|
Net Income
|
-331.2m
USD
|
SNDX Profitability Score
Profitability Due Diligence
Syndax Pharmaceuticals Inc's profitability score is 15/100. The higher the profitability score, the more profitable the company is.

Score
Syndax Pharmaceuticals Inc's profitability score is 15/100. The higher the profitability score, the more profitable the company is.
SNDX Solvency Score
Solvency Due Diligence
Syndax Pharmaceuticals Inc's solvency score is 50/100. The higher the solvency score, the more solvent the company is.

Score
Syndax Pharmaceuticals Inc's solvency score is 50/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
SNDX Price Targets Summary
Syndax Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for
SNDX
is 35.98 USD
with a low forecast of 17.17 USD and a high forecast of 53.55 USD.
Dividends
Current shareholder yield for SNDX is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
SNDX
stock under the Base Case scenario is
16.83
USD.
Compared to the current market price of 9.26 USD,
Syndax Pharmaceuticals Inc
is
Undervalued by 45%.